1. Aruffo A, Kanner SB, Sgroi D, Ledbetter JA, Stamenkovic I (1992) CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling. Proc Natl Acad Sci USA 89: 10242
2. Becker W, Lsuer U, Marienhagen J, Goldenberg DM, Wolf F (1992) Comparison of Tc-99m-antigranulocyte (NCA-95) Fab?-fragments and scintigraphy with In-111-oxin/Tc-99m-HMPAO-labelled leukocytes in infectious diseases. J Nucl Med 33: 903
3. Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS (1992) Therapy with unlabeled and131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts. Cancer Res 52:6476
4. DeNardo SJ, DeNardo GL, O'Grady LF, Hu E, Sytsma VM, Mills SL, Levy NB, Macey DJ, Miller CH, Epstein AL (1988) Treatment of B cell malignancies with131I Lym-1 monoclonal antibodies. Int J Cancer [Suppl] 3: 96
5. Dorken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler LM (1986) HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 136: 4470